Clozapine treatment of schizophrenic patients ‐ PLASMA CONCENTRATION AND COAGULATION FACTORS
- 1 February 1977
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 55 (2) , 123-126
- https://doi.org/10.1111/j.1600-0447.1977.tb00148.x
Abstract
Male chronic schizophrenic hospitalized patients (11), treated with a constant dose of clozapine (200-600 mg daily) as their only neuroleptic medication, were studied for a long period of time (minimum 12 wk). Wide variations in the plasma concentration of clozapine were found in different patients who received the same oral dose, as well as great changes from week to week in the individual patient given a constant dose. The plasma levels of clozapine appeared to have no correlation with either the clinical effect or the side effects. No differences with regard to coagulation factors were found between the patients and the controls.Keywords
This publication has 5 references indexed in Scilit:
- Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine.Published by Wiley ,1975
- Resuspension of platelets: enhanced 5-hydroxytryptamine-induced aggregation in chlorpromazine treated patients due to changes in platelet properties.Published by Wiley ,1975
- Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patientsPsychopharmacology, 1975
- CLOZAPINE AND HALOPERIDOL IN A SINGLE‐BLIND CROSS‐OVER TRIAL: THERAPEUTIC AND BIOCHEMICAL ASPECTS IN THE TREATMENT OF SCHIZOPHRENIAActa Psychiatrica Scandinavica, 1974
- The effect of neuroleptic drug treatment on plasma fibrinogen concentrations in schizophrenic states.Journal of Neurology, Neurosurgery & Psychiatry, 1968